Opthea-spon Adr Share Price Today
(NASDAQ: OPT)

Name: Opthea-spon Adr Share Price Today (NASDAQ: OPT) - Opthea-spon Adr Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Opthea-spon Adr share price is $3.98 & ₹346.14 as on 6 Mar 2025, 2.30 'hrs' IST

$3.98

▲

0.43

(12.11%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Opthea-spon Adr share price in Dollar and Rupees. Guide to invest in Opthea-spon Adr stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Opthea-spon Adr, along with analyst recommendations, forecasts, and comprehensive financials.

Opthea-spon Adr share price movements

Today's Low: $3.74
Today's High: $4.04
$3.98
6.03%
Downside
Day's Volatility :7.43%
Upside
1.49%
52 Weeks Low: $1.79
52 Weeks High: $6.30
$3.98
55.03%
Downside
52 Weeks Volatility :71.59%
Upside
36.83%

Opthea-spon Adr (OPT) Returns

Period	Opthea Ltd-spon Adr	Sector (Health Care)	Index (Russel 2000)
3 Months	-2.74%	2.1%	0.0%
6 Months	19.13%	-4.1%	0.0%
1 Year	10.59%	2.2%	0.0%
3 Years	-34.5%	11.8%	-11.6%

Opthea-spon Adr (OPT) Key Statistics

in dollars & INR

Previous Close	$3.55
Open	$4.18
Today's High	$4.04
Today's Low	$3.74
Market Capitalization	$840.0M
Today's Volume	$63.4K
52 Week High	$6.3
52 Week Low	$1.79
Revenue TTM	$208.9K
EBITDA	$-183.2M
Earnings Per Share (EPS)	$-2.76
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-3383.08%

How to invest in Opthea-spon Adr Stock (OPT) from India?

It is very easy for Indian residents to invest directly in Opthea-spon Adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Opthea-spon Adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Opthea-spon Adr or OPT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Opthea-spon Adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Opthea-spon Adr shares which would translate to 0.219 fractional shares of Opthea-spon Adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Opthea-spon Adr, in just a few clicks!

Returns in Opthea-spon Adr (OPT) for Indian investors in Rupees

The Opthea-spon Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Opthea-spon Adr investment value today

Current value as on today

₹1,28,950

Returns

₹28,950

(+28.95%)

Returns from Opthea-spon Adr Stock

₹23,988 (+23.99%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Opthea-spon Adr (OPT)

-54%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Opthea-spon Adr Stock from India on INDmoney has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Opthea-spon Adr

VGI PARTNERS PTY Ltd
1.89%
Baker Bros Advisors LP
1.41%
HSBC Holdings PLC
0.09%
Millennium Management LLC
0.04%
UBS Group AG
0.02%
Citadel Advisors Llc
0.01%

Analyst Recommendation on Opthea-spon Adr

Sell

11%Buy

33%Hold

55%Sell

Based on 9 Wall street analysts offering stock ratings for Opthea-spon Adr(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Opthea-spon Adr Stock (OPT)

What analysts predicted

Upside of 205.7%

Target:

$12.17

Current:

$3.98

Insights on Opthea-spon Adr Stock (Ticker Symbol: OPT)

Price Movement
In the last 7 days, OPT stock has moved down by -23.2%
Decreasing Revenue
Revenue is down for the last 2 quarters, 93.18K → 89.38K (in $), with an average decrease of 4.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, -48.92M → -185.98M (in $), with an average decrease of 58.8% per quarter
OPT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 60.0%
OPT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 79.4%

OPT Opthea-spon Adr Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$78.2K	-
Net Income	$-10.4M	↑ 20.44%
Net Profit Margin	-13.3K%	-

	FY20	Y/Y Change
Revenue	$40.7K	↓ 47.5%
Net Income	$-7.6M	↓ 25.9%
Net Profit Margin	-18.8K%	↓ 5468.89%

	FY21	Y/Y Change
Revenue	$70.2K	↑ 55.74%
Net Income	$-46.4M	↑ 448.59%
Net Profit Margin	-66.1K%	↓ 47325.99%

	FY22	Y/Y Change
Revenue	$87.9K	↑ 35.95%
Net Income	$-90.0M	↑ 110.55%
Net Profit Margin	-102.4K%	↓ 36266.11%

	FY23	Y/Y Change
Revenue	$108.3K	↑ 28.88%
Net Income	$-142.3M	↑ 65.54%
Net Profit Margin	-131.5K%	↓ 29116.11%

	FY24	Y/Y Change
Revenue	$82.8K	↓ 22.65%
Net Income	$-146.3M	↑ 3.95%
Net Profit Margin	-176.7K%	↓ 45195.93%

	Q3 FY22	Q/Q Change
Revenue	$103.2K	↑ 133.08%
Net Income	$-40.4M	↓ 24.48%
Net Profit Margin	-39.1K%	↑ 81628.83%

	Q4 FY22	Q/Q Change
Revenue	$52.5K	↓ 49.5%
Net Income	$-77.7M	↑ 90.98%
Net Profit Margin	-148.0K%	↓ 108840.57%

	Q1 FY23	Q/Q Change
Revenue	$94.0K	↑ 80.94%
Net Income	$-32.7M	↓ 57.49%
Net Profit Margin	-34.8K%	↑ 113203.15%

	Q2 FY23	Q/Q Change
Revenue	$56.0K	↓ 40.79%
Net Income	$-65.1M	↑ 97.92%
Net Profit Margin	-116.2K%	↓ 81444.87%

	Q4 FY23	Q/Q Change
Revenue	$62.3K	↑ 11.81%
Net Income	$-98.6M	↑ 52.22%
Net Profit Margin	-158.2K%	↓ 41999.78%

	Q2 FY24	Q/Q Change
Revenue	$59.4K	↓ 4.07%
Net Income	$-123.5M	↑ 26.16%
Net Profit Margin	-208.1K%	↓ 49858.02%

	FY19	Y/Y Change
Profit	$61.7K	-

	FY20	Y/Y Change
Profit	$-316.1K	↓ 615.81%

	FY21	Y/Y Change
Profit	$-366.6K	↑ 4.76%

	FY22	Y/Y Change
Profit	$-75.5K	↓ 77.62%

	FY23	Y/Y Change
Profit	$-60.0K	↓ 16.86%

	FY24	Y/Y Change
Profit	$82.8K	↓ 239.59%

	Q3 FY22	Q/Q Change
Profit	$60.4K	↓ 179.87%

	Q4 FY22	Q/Q Change
Profit	$-28.4K	↓ 146.65%

	Q1 FY23	Q/Q Change
Profit	$51.5K	↓ 282.98%

	Q2 FY23	Q/Q Change
Profit	$-30.0K	↓ 157.88%

	Q4 FY23	Q/Q Change
Profit	$9.9K	↓ 133.19%

	Q2 FY24	Q/Q Change
Profit	$-88.7K	↓ 1002.3%

	FY19	Y/Y Change
Operating Cash Flow	$-8.3M	↓ 40.25%
Investing Cash Flow	$223.0K	↓ 1032.61%
Financing Cash Flow	$4.3M	↑ 1431.36%

	FY20	Y/Y Change
Operating Cash Flow	$-3.9M	↓ 52.24%
Investing Cash Flow	$328.2K	↑ 48.22%
Financing Cash Flow	$23.2M	↑ 444.31%

	FY21	Y/Y Change
Operating Cash Flow	$-46.6M	↑ 973.15%
Investing Cash Flow	$501.4K	↑ 37.99%
Financing Cash Flow	$119.7M	↑ 365.79%

	FY22	Y/Y Change
Operating Cash Flow	$-69.1M	↑ 61.1%
Investing Cash Flow	$-11.9K	↓ 102.58%
Financing Cash Flow	$166.3K	↓ 99.85%

	FY23	Y/Y Change
Operating Cash Flow	$-120.5M	↑ 82.28%
Investing Cash Flow	$-14.7K	↑ 29.83%
Financing Cash Flow	$167.1M	↑ 105002.38%

	Q3 FY22	Q/Q Change
Operating Cash Flow	$-36.3M	↓ 12.18%
Investing Cash Flow	$-2.4K	↓ 53.99%
Financing Cash Flow	$87.5M	↓ 226477.28%

	Q4 FY22	Q/Q Change
Operating Cash Flow	$-69.8M	↑ 90.98%
Investing Cash Flow	$-2.4K	↑ 0.0%
Financing Cash Flow	$168.5M	↑ 90.98%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$-25.6M	↓ 62.89%
Investing Cash Flow	$-5.0K	↑ 112.74%
Financing Cash Flow	$45.0K	↓ 99.97%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-50.4M	↑ 95.63%
Investing Cash Flow	$-5.0K	↑ 0.0%
Financing Cash Flow	$-1.3M	↓ 3052.2%

Opthea-spon Adr Technicals Summary

Sell

Neutral

Buy

Opthea-spon Adr is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Opthea-spon Adr (OPT) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Opthea Ltd-spon Adr	-30.93%	19.13%	10.59%	-34.5%	-71.14%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Opthea Ltd-spon Adr	NA	NA	NA	-0.33	-33.83	-0.73	NA	-0.14
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Opthea Ltd-spon Adr	Sell	$840.0M	-71.14%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Opthea-spon Adr

Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States. Its development activities are based on the intellectual property portfolio covering vascular endothelial growth factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company's lead product candidate is sozinibercept (OPT-302), a biologic drug in Phase 3 clinical trials designed to inhibit VEGF-C and VEGF-D and complement VEGF-A inhibitors for the treatment of wet age-related macular degeneration and diabetic macular edema. It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in South Yarra, Australia.

Organization	Opthea-spon Adr
Employees	33
CEO	Dr. Frederic Guerard M.S., Pharm.D.
Industry	Health Technology

Management People of Opthea-spon Adr

Name	Title
Dr. Frederic Guerard M.S., Pharm.D.	Chief Executive Officer
Dr. Megan Baldwin M.A.I.C.D., MAICD, Ph.D.	Founder & Chief Innovation Officer
Ms. Karen Adams CPA	VP of Finance & Company Secretary
Mr. Thomas Charles Reilly	Chief Financial Officer
Mr. Kevin Bitter	VP of Strategy & Corporate Development
Mr. Anand Sundaram	Vice President Marketing
Dr. Fang Li Ph.D.	Senior Vice President of Regulatory Affairs
Dr. Julie Clark M.D., M.S.	Senior Vice President of Clinical Development
Dr. Arshad M. Khanani M.A., M.D.	Chief Medical Advisor & Chairman of Medical Advisory Board
Ms. Jen Watts	VP Global Clinical Operations

Important FAQs about investing in OPT Stock from India :

What is Opthea-spon Adr share price today?

Opthea-spon Adr share price today stands at $3.98, Open: $4.18 ; Previous Close: $3.55 ; High: $4.04 ; Low: $3.74 ; 52 Week High: $6.30 ; 52 Week Low: $1.79.

The stock opens at $4.18, after a previous close of $3.55. The stock reached a daily high of $4.04 and a low of $3.74, with a 52-week high of $6.30 and a 52-week low of $1.79.

Can Indians buy Opthea-spon Adr shares?

Yes, Indians can invest in the Opthea-spon Adr (OPT) from India.

With INDmoney, you can buy Opthea-spon Adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Opthea-spon Adr at zero transaction cost.

How can I buy Opthea-spon Adr shares from India?

It is very easy to buy Opthea-spon Adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Opthea-spon Adr (OPT) be purchased?

Yes, you can buy fractional shares of Opthea-spon Adr with INDmoney app.

What are the documents required to start investing in Opthea-spon Adr stocks?

To start investing in Opthea-spon Adr, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.